Acute Fatty Liver Disease of Pregnancy in the Second Trimester by Faraz Afridi, Michael Feely, Raju Reddy

Get full text

New aspects of non-alcoholic fatty liver disease by V. V. Tsukanov, E. V. Kasparov, Yu. L. Tonkikh, A. V. Vasyutin

“…To analyze modern data on pathogenesis and principles of treatment of non-alcoholic fatty liver disease (NAFLD).Key points. Now concepts on genetic determinants of NAFLD and diagnostics methods develop rapidly. …”
Get full text

Improvement of non-alcoholic fatty liver disease treatment by P. I. Seliverstov, V. G. Radchenko

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Liver Transplantation for Hepatitis C and Alcoholic Liver Disease by Marco Carbone, James Neuberger

“…End-stage liver disease due to hepatitis C (HCV) and cirrhosis from alcohol (ALD) are the commonest indications for liver transplantation in the western countries. …”
Get full text

Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children by Asma Deeb, Salima Attia, Samia Mahmoud, Ghada Elhaj, Abubaker Elfatih

“…We aim to assess the prevalence of dyslipidemia and fatty liver disease (FLD) in overweight and obese children and analyze the association between different anthropometric measures with dyslipidemia and fatty liver disease. …”
Get full text

EFFICACY OF THIONONTRITE-S FOR PREVENTION OF METABOLIC LIVER DISEASE IN CATTLE by Ye. V. Tyapkina, M. P. Semenenko, Ye. V.  Kuzminova, A. A.  Abramov

“…The study data of the efficacy of thionontrite-S-complex preparation in the prevention of metabolic liver disease of cattle are presented. Administration of the preparation to 6–7-month-old cows in dry period for two weeks at a dose of 0.3 g/kg of body weight corrects biochemical homeostasis and prevents the development of pathogenetic shifts during metabolic liver disease. …”
Get full text

The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases by Lin Li, Panyang Xu, Qi Zhou, Jiancheng Xu

“…When dysregulated, TFH cells may represent an important mechanism that contributes to a heightened humoral response and autoantibody production in autoimmune liver diseases (AILDs). TFH cells participate in the immune response associated with AILDs by expressing surface receptors such as programmed cell death protein-1, C-X-C motif chemokine receptor 5, and inducible T cell costimulators, as well as cytokines such as interleukin-21. …”
Get full text

Peroxisome proliferator–activated receptor delta and liver diseases by Tomoo Yamazaki, Edward E. Cable, Bernd Schnabl

“…PPAR-delta not only regulates physiologic processes of lipid, glucose, and bile acid metabolism but also attenuates pathologic responses to alcohol metabolism, inflammation, fibrosis, and carcinogenesis, and is considered an important therapeutic target in liver diseases. Promising results have been reported in clinical trials for PPAR-delta agonists in liver disease, and the selective agonist seladelpar was recently conditionally approved in the United States as a new treatment option for primary biliary cholangitis. …”
Get full text

Biomarkers in Liver Disease: Emerging Methods and Potential Applications by Guruprasad P. Aithal, Neil Guha, Jonathan Fallowfield, Laurent Castera, Andrew P. Jackson

Get full text

Microbiota and metabolic dysfunction associated with steatotic liver disease by Q. Zhu, S. Francque, W. Kwanten

“…Disease progression in metabolic dysfunction-associated steatotic liver disease (MASLD) is driven by multiple mechanisms that act together in genetically predisposed subjects. …”
Get full text

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease by Myrsini Orfanidou, Stergios A. Polyzos

Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text

Alcohol-induced liver disease: primary and secondary prevention by S. V. Plyusnin, K. V. Ivashkin, A. N. Bobrov, S. A. Belyakin, I. V. Plyusnina

Get full text

Algorithm of management of patient with alcohol-induced liver disease by M. V. Mayevskaya, M. A. Morozova

Subjects: “…alcohol-induced liver disease…”
Get full text

Recent trends in studying of alcohol-induced liver disease by I. I. Komkova, M. S. Zharkova, M. V. Mayevskaya

Subjects: “…alcoholic liver disease…”
Get full text

NK Cell Subtypes as Regulators of Autoimmune Liver Disease by Guohui Jiao, Bangmao Wang

“…However, the precise regulatory mechanisms at work in autoimmune liver diseases remain to be identified. In this review, we focus on recent research with NK cells and their potential role in the development of autoimmune liver disease.…”
Get full text

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications by Abdelfattah El Ouaamari, Kaori Minehira

Get full text

Treatment of HCV infection in patients with steatotic liver disease by Robert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, Justyna Janocha-Litwin, Dorota Dybowska, Marek Sitko, Łukasz Socha, Beata Lorenc, Jakub Klapaczyński, Jakub Brodowski

Subjects: Get full text

The Role of Liver Biopsy in the Management of Patients with Liver Disease by Florence Wong

“…The role of liver biopsy in the diagnosis and management of liver disease is a controversial issue even among hepatologists. …”
Get full text

The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease by James P. Hardwick, Byoung-Joon Song, Paul Rote, Charles Leahy, Yoon Kwang Lee, Alexandra Rudi Wolf, Danielle Diegisser, Victor Garcia

Subjects: Get full text

Principles of effective out-patient diagnostics of diffuse liver diseases by Komova A. G., M. V. Mayevskaya, V. T. Ivashkin

Subjects: “…diffuse liver diseases…”
Get full text